FIT System & Assay Development
Colorectal Cancer Screening
CommercialActive
Key Facts
About Sentinel Diagnostics
Sentinel Diagnostics is a well-established, independent IVD developer and manufacturer based in Italy, with over 40 years of history and a workforce exceeding 200 employees. It operates a diversified portfolio spanning clinical chemistry reagents, patented FIT collection systems, and molecular diagnostic assays, including its STAT-NAT® line of real-time PCR tests. The company is revenue-generating, invests significantly in R&D, and maintains a global distribution network through partnerships and direct sales. Its strategic focus is on innovation, quality, and providing customized OEM solutions to diagnostic partners worldwide.
View full company profileTherapeutic Areas
Other Colorectal Cancer Screening Drugs
| Drug | Company | Phase |
|---|---|---|
| Shield (ECLIPSE Study) | Guardant Health | FDA Approved |
| Urine cfDNA Test for Colon Cancer Screening | JBS Science | Development |
| iFOB | Pangea Laboratory | Commercial |
| ColoHealth | New Day Diagnostics | Approved |
| CRC Screening Program | Polymedco | Commercial |
| SimpleScreen CRC | Freenome | Commercial (as LDT) |
| ColoScape™ / QuantiDNA™ | DiaCarta | Commercial |
| ColoSense | Geneoscopy | Approved |
| At-Home Colorectal Cancer Screening | SNT Biotech | Commercial |
| Next-Generation Cologuard® | Exact Sciences | Development |
| ColoAlert® | Mainz Biomed | Pivotal Trial |